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Background
Introduction: Current guidelines for the functional eva-
luation of bioprosthetic heart valves recommend the
effective orifice area (EOA) as the product of the trans-
valvular stroke volume divided by Doppler derived dia-
stolic time velocity integral (TVI). Phase contrast CMR
may offer an alternative imaging modality to assess bio-
prosthetic valve EOA when Doppler methods are tech-
nically limited or unreliable.
Methods
Our circulatory loop includes a mock ventricle and a
heart valve imaging chamber that has been fabricated
using MRI-compatible components. In this study 3 dif-
ferent sized stented porcine mitral valve bioprostheses
were evaluated (27 mm, 29 mm, 31 mm) replicating
three different hemodynamic conditions with forward
stroke volume of 70 ml, 90 ml and 110 ml respectively
at a beat rate of 70 bpm. Imaging was performed with a
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1.5T Siemens Avanto scanner. CMR imaging parameters
consisted of 25 phases, slice thickness 4 mm, spatial
resolution of 138 × 256 and temporal resolution of
49 msec. Phase contrast pulse sequences were acquired
and peak instantaneous velocities were plotted through-
out the diastolic filling period. Stroke volume was mea-
sured by MRI-compatible high fidelity flow transducer.
The velocity time integral of peak velocity was calcu-
lated by tracing the area under the curve and CMR-
EOA (cm2) was calculated by dividing the forward flow
(cm3) by the MRI-derived TVI (cm). Doppler derived
EOA was determined by dividing the stroke volume by
the continuous wave Doppler TVI.
Results
Bioprosthetic mitral valve diastolic flow area was
assessed for 3 different sized valves each at 3 flow
volume conditions (N = 9). Doppler-EOA and CMR-
EOA were measured and compared for each condition.
CMR-derived TVI demonstrated a strong and statisti-
cally significant correlation with Doppler-derived TVI
(r = 0.97, p < 0.001). CMR-EOA also revealed a strong
and statistically significant correlation with Doppler
derived EOA (r = 0.90, p = 0.001). Mean EOA difference
was 0.2 cm2 ± 0.13. The lower temporal resolution of
phase contrast CMR velocity determination may have
led to the lower TVI values and slightly larger EOA cal-
culation compared to Doppler TVI method
Conclusions
In this study we report a novel method to determine
mitral prosthetic valve effective orifice area using phase
contrast CMR values. We demonstrate a strong correla-
tion with the current Doppler standard method to
derive EOA. CMR-derived EOA may be an important
parameter of prosthetic valve function when Doppler
methods are unobtainable or unreliable.
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